GlassScriptPhysician profile
Patricia A Northrup
NPI 1265493191
$2,766.65
in general payments reported to CMS, 2019-2025
25 companies · $601 in 2025
The $601 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $345 · 2022: $501 · 2023: $972 · 2024: $347 · 2025: $601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,797 · Travel and Lodging: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,797.22 |
| Travel and Lodging | $123.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $478.04 | 2022-2025 | Impella |
| Getinge USA Sales, LLC | $300.74 | 2024-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2, Heartstring III Proximal Seal |
| Novartis Pharmaceuticals Corporation | $251.45 | 2021-2024 | |
| Edwards Lifesciences Corporation | $227.77 | 2023 | |
| Amgen INC. | $221.21 | 2021-2023 | Repatha |
| Haemonetics Corporation | $141.70 | 2023 | Teg6s Hemostasis System, Teg5000 Hemostasis Analyzer |
| Medical Device Business Services, INC. | $124.09 | 2024 | Vistaseal |
| Merck Sharp & Dohme LLC | $110.70 | 2021-2025 | Verquvo |
| Atricure, INC. | $103.03 | 2025 | Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2) |
| Baxter Healthcare | $93.29 | 2024-2025 | Preveleak, Coseal |
| Medtronic, INC. | $82.47 | 2025 | Penditure, Avalus |
| Esperion Therapeutics, INC. | $76.46 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $60.56 | 2022-2023 | Xarelto |
| Solventum Corporation | $59.00 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| E.R. Squibb & Sons, L.L.C. | $57.83 | 2022-2023 | Camzyos |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $51.17 | 2021-2023 | |
| Scpharmaceuticals INC. | $49.95 | 2023-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $49.30 | 2023-2025 | Lifevest |
| Pfizer INC. | $44.24 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $44.00 | 2023 | Wainua, Farxiga |
| Boston Scientific Corporation | $38.92 | 2021-2023 | Watchman Access System |
| Terumo Medical Corporation | $28.58 | 2023 | Heartrail |
| Ethicon US, LLC | $26.92 | 2021 | |
| La Jolla Pharmaceutical Company | $24.14 | 2025 | Giapreza |
| Sanofi-Aventis U.S. LLC | $21.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Northrup listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.